Pharma Foods International: Announcements of individual stocks regarding the revision of the full-year performance forecast for the fiscal year ending July 2024 and the revision of dividend estimates (increased dividends).
Pharma Foods International: Confirmation letter
Pharma Foods International: Quarterly report - 27th period, 3rd quarter (02/01/2024 - 04/30/2024)
Pharma Foods International: Supplementary financial statement information for the third quarter of the fiscal year ending in July 2024.
Pharma Foods International: 3rd quarter financial report for the July 2024 period under Japanese accounting standards (consolidated).
Pharma Foods International: Financial results briefing materials for the 2nd quarter of the fiscal year ending July 2024
Pharma Foods: Confirmation Letter
Pharma Foods International: Quarterly Report - 27th Quarter 2 (2023/11/01 - 2024/01/31)
Pharma Foods: Summary of Financial Results for the 2nd Quarter Ending July 2024 [Japanese GAAP] (Consolidated)
Pharma Foods: Notice Concerning Revision of Full-Year Earnings Forecast for the Fiscal Year Ending July 2024
Pharma Foods International: Notice Concerning Determination of Dividends from Surplus Funds (Interim Dividends)
Pharma Foods International: Confirmation letter
Pharma Foods International: Quarterly Report - 27th First Quarter (2023/08/01 - 2023/10/31)
Pharma Foods International: (Correction) Partial correction to the “1st Quarter Financial Results Supplementary Explanatory Materials for the Fiscal Year Ending July 2024”
Pharma Foods International: Supplementary explanation of financial results for the first quarter of the fiscal year ending July 2024
Pharma Foods International: Summary of financial results for the first quarter of the fiscal year ending July 2024 [Japanese GAAP] (consolidated)
Pharma Foods International: Extraordinary Report
Pharma Foods International: Confirmation letter
Pharma Foods International: Securities Report - 26th Period (2022/08/01 - 2023/07/31)
Pharma Foods International: (Corrections/Numerical Data Corrections) Partial Corrections to the “Financial Results Summary for the Fiscal Year Ending 2023/7” [Japanese GAAP] (Consolidated)”
No Data